ethyl 1-(ethylsulfonyl)piperidine-4-carboxylate

Catalog No.: 
ACTGCY092
CAS No.: 
832118-87-3
Molecular Formula: 
C10H19NO4S
Molecular Weight: 
249.1
ethyl 1-(ethylsulfonyl)piperidine-4-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$52.00In stockIn stock
5g97%$157.00In stockIn stock
25g97%$753.00InquiryInquiry
100g97%$2381.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nameethyl 1-(ethylsulfonyl)piperidine-4-carboxylate
IUPAC Nameethyl 1-(ethylsulfonyl)piperidine-4-carboxylate
MDL No.MFCD04969919
Molecular FormulaC10H19NO4S
Molecular Weight249.1
SMILESO=C(C1CCN(S(=O)(CC)=O)CC1)OCC
InChI KeyFILRAUDHQATKGC-UHFFFAOYSA-N
Synonymethyl 1-(ethylsulfonyl)piperidine-4-carboxylate;4-Piperidinecarboxylic acid, 1-(ethylsulfonyl)-, ethyl ester
CAS No.832118-87-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302
Precautionary Statement(s)
P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACTGCY092 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEXNQ621 route compound structure diagram
    ACEXNQ621147636-76-8In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTGCY092 route product structure diagram
    ACTGCY092832118-87-3In Stock
Inquiry

2. ACTGCY092 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEXNQ621 route compound structure diagram
    ACEXNQ621147636-76-8In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTGCY092 route product structure diagram
    ACTGCY092832118-87-3In Stock
Inquiry

3. ACTGCY092 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTGCY092 route product structure diagram
    ACTGCY092832118-87-3In Stock
Inquiry

Comments (0)